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The authors of these reflections are a generation apart, yet
their career paths have much in common. After training in
medicine, they both followed the call of “real science” to dis-
cover a passion for the world of RNAs, a little corner of which
they are now exploring jointly. This is a brief account of these
meanderings.
Walter Keller: For me the turning point came when, as a
resident in human genetics, I read Jim Watson’s 1965
“Molecular Biology of the Gene,” which was a thrilling reve-
lation. After a circuitous postdoctoral journey via the Johns
Hopkins University Medical School and the National
Institutes of Health I was appointed a Senior Staff Investiga-
tor in the Tumor Virus Group of the Cold Spring Harbor
Laboratory, which was directed by Jim Watson. I worked
with such illustrious colleagues as Bob Crouch, Ashley
Dunn, Joe Sambrook, Phil Sharp, John Arrand, Rich Roberts,
Bill Sugden and others. By purifying topoisomerase I and us-
ing it to generate circular topoisomers of SV40 DNA, in 1975
I managed to determine the number of superhelical turns of
native SV40 DNA. When showing these results to Francis
Crick, I was extremely surprised by his pointing out that I
had shown, in fact, that the Watson–Crick structure of
DNA must be correct. Ironically, I was not aware that there
was a group of heretic X-ray crystallographers that had pro-
posed an alternative “side by side model” of the DNA struc-
ture. My fame did not last long, because soon afterwards all
doubts were resolved by X-ray crystallography of synthetic
double-helices.
The 1970’s saw the characterization of fundamental steps
of gene expression. I concentrated on the purification of
RNA polymerase II and of other enzymes, such as poly(A)
polymerase and RNase H from HeLa cells. However, in
returning to the University of Heidelberg in the summer
of 1976, I missed the dramatic events that surrounded the
discovery of pre-mRNA splicing during the following winter
by Phil Sharp (then at MIT) and Louise Chow, Tom Broker
and Rich Roberts at Cold Spring Harbor. In an era preceding
the ubiquitous presence of mobile devices I was taken entirely
by surprise by the reports that were presented at the 1977
Cold Spring Harbor Symposium.
As group leader at the German Cancer Research Center
in Heidelberg I entered the race for a systemwith which splic-
ing could be reproduced in vitro. In 1983, Nouria Hernandez
accomplished this by uncoupling transcription from splic-
ing. David Frendewey studied the stepwise assembly of the
mammalian spliceosome and Angela Krämer and Reinhard
Lührmann showed in 1984 that the U1 snRNP recognizes
the 5′ splice site by base pairing with the 5′ splice site of in-
trons. In the years that followed, the space between genes
and cellular processes started to be filled in increasing detail.
The world of RNAs became larger and larger, RNAwas found
at the core of the ribosome, the RNA Society was established
in 1993, and the RNA journal followed shortly after. I chose
to pursue projects on pre-mRNA splicing, 3′-end processing
and RNA editing, since 1983 at the Biozentrum in Basel, with
the help of of a large number of very competent students
and postdocs, without whom I would have accomplished
very little and to whom I am very grateful. The key players
were Angela Krämer, Elmar Wahle, Joachim Lingner, Ursula
Rüegsegger, Pascal Preker, Isabelle Kaufmann, Andrea
Kyburz, Lionel Minvielle-Sebastia, Silvia Barabino, Mary
O’Connell, André Gerber, Jeannette Wolf, Stepanka Vana-
cova, Bernhard Dichtl, Christiane Rammelt and Georges
Martin. After retiring in 2008 I had the good fortune to be
able to continue the adventure with the support of grants
from the Swiss National Science foundation. I have collabo-
rated with Mihaela on further characterizing pre-mRNA 3′
end processing taking advantage of various high-throughput
approaches that have emerged in the recent years.
Mihaela Zavolan:As a student in computational biology at
the University of New Mexico, the Los Alamos National
Laboratory and the Santa Fé Institute I was initially grappling
with the mystery of adaptive immune systems, simulating the
dynamics of immune responses to understand their speed
and efficiency. At some point I found that the Genbank da-
tabase of the National Center of Biotechnology Information
(NCBI) already catalogued hundreds of sequences of im-
mune receptor genes, annotated with functional domains.
Analyzing these genes from the perspective of empirically in-
ferred sequence-dependent rates of somatic hypermutation,
Tom Kepler (then at North Carolina State University) and
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I found that evolution has shaped the codon bias of immune
receptor genes such that somatic hypermutation preferential-
ly targets the antigen-binding regions and avoids the struc-
tural parts of these molecules. Furthermore, by comparing
the sequence-specific bias of somatic hypermutation with
that of mutations that occurred during evolution, we inferred
that somatic hypermutation appears to be the superposition
of a mutational process similar to that taking place during
evolution and a specific process that targets G/C nucleotides.
The specific component is now known to be the activation-
induced deaminase (AID), while the general component in-
volves mismatch repair proteins and DNA polymerase eta.
Then and now I find it astounding that computational anal-
yses of nucleic acid sequence can bring us so far to under-
standing how organisms function.
As a postdoctoral fellow at the Rockefeller University I
started to look at RNAs. I had the chance to work with
hot-off-the-press mouse genome and transcript sequences,
searching for functionally important splicing isoforms and
rather finding that much of the observed transcript varia-
tion comes from stochasticity in the splicing process. At
the Rockefeller University, I serendipitously joined Tom
Tuschl in the race for finding miRNA genes in flies, fishes, vi-
ruses, humans and mice. MiRNAs burst on the scene in the
year 2000, when two papers from the Ruvkun lab reported
on the let-7 miRNA, which is perfectly conserved between
worms and humans. The founder of this family of molecules
was, however, discovered much earlier, when worm develop-
mental phenotypes were traced to a gene encoding the very
small non-coding RNA lin-4 by the Ruvkun and Ambros
labs. Also in the early 1990’s studies from the Jorgensen lab
in plants and from the Macino group in fungi found that in-
troduction of transgenes led to the silencing of homologous
genes in trans. All of these findings converged in the years that
followed onto the RNA interference (RNAi) pathway, which
probably originated as a mechanism by which organisms de-
fended themselves against foreign genetic material, but has
been co-opted in many guises in a variety of cellular process-
es, ranging from transcriptional silencing and silencing of
repeat elements to the repression of protein production.
Because RNAi can also be triggered by exogenous small inter-
fering RNA (siRNA), it has become part of the basic molecu-
lar biology toolbox.
miRNAs are only one of many classes of RNAs that have
been discovered in the recent years. They are quasi-ubiqui-
tous, being encoded by genomes as small as those of the poly-
omaviruses, which are ∼5 kilobases in length, to the human
genome, which is ∼3 gigabases and that of the Norway
spruce, which is larger than 20 gigabases. Their roles in
gene silencing are well established. Many other categories
of small RNAs have been recently uncovered and are intense-
ly studied. For example, the piRNAs regulate the expression
primarily of repeat elements in germ cells, embryos and
stem cell gametogenesis in animals. Furthermore, short
RNA by-products are generated from transcription start sites
and splice sites and during other steps of RNA process-
ing. Whether these molecules carry out independent func-
tions is currently unknown. Intriguingly, some molecules
that have been viewed as aberrant products of RNA
processing reactions such as the circular RNAs, reported by
the Bailleul group twenty years ago, were recently found by
the Rajewsky and Kjems labs to have important biological
functions.
A technology that is currently taking the world by storm
makes use of the RNA-guided Cas enzymes, that bacteria
have evolved as an anti-viral defence mechanism to target
DNA and the Charpentier and Doudna groups have explored
as biotechnology tools. The range of applications of this
CRISPR (clustered regularly interspaced short palindromic
repeats)/Cas system is continuously expanding and currently
includes processes from transcription regulation to genome
editing. The fantastic versatility of nucleic acids comes to a
large extent from the simple but powerful base-pairing rules
that not only enable transmission of genetic information but
also allow us to interrogate a variety of aspects of cellular
functions by sequencing RNAs or DNAs.
The quest for fast, cost-effective and high-throughput
sequencing technologies gained momentum after the ini-
tial draft of the human genome was published in 2001. A va-
riety of sequencing platforms emerged and their applications
range from the more “mundane” sequencing of transcripts
to estimate gene expression to the global analysis of mRNA
translation in whole cells as well as specific subcellular com-
partments with approaches developed by the Weissmann
lab. The sensitivity of sequencing methods is increasing as
well, to the point that mRNA expression profiles can current-
ly be obtained from single cells, and the van Oudenaarden
group further improved the accuracy of mRNA expression
level estimation by using molecular bar codes. Image-based
transcriptomics approaches such as that developed by the
Pelkmans lab have also been used for parallel quantification
of RNA species in a large number of cells. These methods
enable investigations into the sources and consequences of
stochasticity in gene expression, particularly for cell differen-
tiation and development.
Experiments that probe the accessibility of nucleotides to
either Selective 2′-Hydroxyl Acylation and Primer Extension
(SHAPE) or to endonucleases that are specific for double-
stranded RNA (RNase V1) or single-stranded RNA (RNase
S1) coupled with deep sequencing have provided the first
insights into the RNA secondary structure in vivo. Surpris-
ingly, the Weissmann group showed that mRNAs are actively
unfolded in vivo. Some RNAs such as the ribosomal and
spliceosomal RNAs are known to undergo specific modifica-
tions such as methylation and pseudo-uridylation that are
presumably important for their stability and function. Most
likely, only a very small fraction of the modification sites
is currently known, and here again, methods for mapping
RNA modifications genome-wide that are based on RNA se-
quencing and analysis have started to emerge. For example,
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the sites of ribose 2′-O-methylation can be mapped taking
advantage of the fact that these bases are resistant to alkaline
hydrolysis, in contrast to their non-modified variants. This
approach has been employed by the Nielsen lab to map mod-
ification sites on yeast rRNAs and we are awaiting the scaling
of the method to the entire transcriptome.
Synthetic biology applications that make use of RNAs have
also started to emerge and there is no doubt that the kaleido-
scopic world of RNAs will continue to expand and complex-
ify. Current challenges include increasing the resolution of
the measurement technologies to the extent that we will be
able to perform single molecule sequencing, localize individ-
ual long and small RNAs within individual cells and follow
the dynamics of RNA-protein interactions in vivo. Notably,
the challenge that has been brought by the high-throughput
measurement technologies, namely how to integrate large
amounts of data into a conceptual understanding and trans-
late them into predictive models, remains. Examples of ap-
proaches that have been proposed include the “splicing
code,” developed by the Frey group for the prediction of tis-
sue-specific splicing patterns and the “motif activity-re-
sponse analysis” developed by the van Nimwegen group for
the identification of key regulators of mRNA levels. It will
be extremely interesting to learn what the application of
such approaches to the emerging personalized high-through-
put data will tell us about human diseases.
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